- Conditions: Pharmacokinetics of Isavuconazole; Pharmacokinetics of Methadone; Healthy Volunteers
Interventions: Drug: Isavuconazole; Drug: Methadone
Sponsors: Astellas Pharma Inc; Astellas Pharma Global Development, Inc.; Basilea Pharmaceutica International Ltd
Recruiting - verified April 2012 - Condition: Low Back Pain
Interventions: Drug: Methadone; Drug: Buprenorphine/naloxone
Sponsors: State University of New York at Buffalo; State University of New York at Buffalo
Recruiting - verified March 2012 - Conditions: Substance-related Disorders; HIV Risk Behavior
Interventions: Behavioral: Therapeutic Workplace; Drug: Methadone
Sponsors: Johns Hopkins University; Johns Hopkins University; National Institute on Drug Abuse (NIDA)
Not yet recruiting - verified March 2012 - Condition: Postoperative Pain
Interventions: Drug: Methadone; Drug: Hydromorphone
Sponsors: NorthShore University HealthSystem Research Institute; NorthShore University HealthSystem Research Institute
Recruiting - verified March 2012 - Conditions: Pain, Postoperative; Chronic Pain
Interventions: Drug: Methadone; Drug: Fentanyl
Sponsors: NorthShore University HealthSystem Research Institute; NorthShore University HealthSystem Research Institute
Recruiting - verified February 2012 - Condition: Rett Syndrome
Interventions: Drug: dextromethorphan; Drug: placebo
Sponsors: FDA Office of Orphan Products Development; FDA Office of Orphan Products Development
Not yet recruiting - verified January 2012 - Condition: Chronic Pain
Intervention: Drug: Hydrocodone
Sponsors: NEMA Research, Inc.; NEMA Research, Inc.; Covidien; International Clinical Research Institute
Recruiting - verified April 2012 - Conditions: Overactive Bladder; Overactive Urinary Bladder
Interventions: Drug: MK-4618; Drug: Tolterodine ER; Drug: MK-1468 and Tolterodine ER; Other: Placebo (MK-4618); Other: Placebo (Tolterodine ER); Drug: Prophylactic Antibiotic
Sponsors: Merck; Merck
Recruiting - verified February 2012 - Condition: Chronic Low Back Pain
Interventions: Drug: Hydrocodone bitartrate q24h film-coated tablets; Drug: Placebo to match hydrocodone bitartrate q24h tablets
Sponsors: Purdue Pharma LP; Purdue Pharma LP
Recruiting - verified May 2012 - Conditions: Hepatitis C; Medication Adherence
Interventions: Other: enhanced DOT (both pegylated interferon alfa-2a and ribavirin); Other: standard DOT (PEG-DOT control arm)
Sponsors: Albert Einstein College of Medicine of Yeshiva University; Albert Einstein College of Medicine of Yeshiva University; National Institute on Drug Abuse (NIDA)
Recruiting - verified September 2011 - Condition: Diabetic Macular Edema
Intervention: Drug: Dextromethorphan
Sponsors: National Institutes of Health Clinical Center (CC); National Eye Institute (NEI)
Recruiting - verified August 2011 - Condition: Opiate Dependence
Interventions: Other: Patient-Centered Methadone Treatment; Other: Methadone Treatment as usual
Sponsors: Friends Research Institute, Inc.; Friends Research Institute, Inc.
Recruiting - verified September 2011 - Condition: Opiate Dependence
Intervention: Behavioral: employment based reinforcement
Sponsors: Johns Hopkins University; Johns Hopkins University; National Institute on Drug Abuse (NIDA)
Recruiting - verified April 2010 - Condition: Analgesia After ED Discharge for Extremity Injuries
Intervention: Drug: Oral Opioid Pain Medicine
Sponsors: Montefiore Medical Center; Montefiore Medical Center
Recruiting - verified December 2011 - Condition: Cocaine Abuse
Intervention: Behavioral: prize contingency management
Sponsors: University of Connecticut Health Center; University of Connecticut Health Center; National Institute on Drug Abuse (NIDA)
Recruiting - verified November 2011 - Condition: Chronic Nonmalignant and Nonneuropathic Pain
Intervention: Drug: Hydrocodone bitartrate q24h film-coated tablets
Sponsors: Purdue Pharma LP; Purdue Pharma LP
Recruiting - verified April 2012 - Conditions: Nicotine Dependence; Opiate Dependence
Interventions: Behavioral: Intensive, tailored intervention; Behavioral: NJ Quitline Referral
Sponsors: University of Medicine and Dentistry New Jersey; University of Medicine and Dentistry New Jersey; National Institute on Drug Abuse (NIDA)
Recruiting - verified January 2012 - Conditions: Tobacco Use Disorder; Medication Adherence
Intervention: Behavioral: Varenicline treatment as usual or directly observed therapy
Sponsors: Albert Einstein College of Medicine of Yeshiva University; Albert Einstein College of Medicine of Yeshiva University; National Institute on Drug Abuse (NIDA)
Recruiting - verified February 2012 - Conditions: Chronic Pain; Opiate Dependence
Interventions: Behavioral: Cognitive-Behavioral Therapy for Pain and Opioid Dependence; Behavioral: Methadone Drug Counseling
Sponsors: Yale University; Yale University; National Institute on Drug Abuse (NIDA)
Recruiting - verified May 2012 - Condition: Chronic Rhinitis
Interventions: Drug: Placebo; Drug: Guaifenesin
Sponsors: Virginia Commonwealth University; Virginia Commonwealth University; Pfizer
Recruiting - verified May 2011 - Conditions: Premature Birth of Newborn; Critically Ill
Interventions: Drug: Methadone; Drug: Methadone
Sponsors: Children's Research Institute; Children's Research Institute
Recruiting - verified April 2012 - Conditions: Mechanically Ventilated Neonates,; Painful Procedures in Newborns
Intervention: Drug: Codeine
Sponsors: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified February 2012 - Condition: Urinary Bladder, Overactive
Interventions: Drug: MK-4618 low-dose; Drug: MK-4618 mid-low dose; Drug: MK-4618 mid-high dose; Drug: tolterodine ER; Drug: Placebo for MK-4618; Drug: Placebo for tolterodine ER; Drug: MK-4618 high dose
Sponsors: Merck; Merck
Recruiting - verified May 2012 - Condition: Overactive Bladder
Interventions: Drug: Tolterodine ER; Drug: Placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Conditions: Tonsillitis; Pain
Interventions: Drug: Codeine with acetaminophen; Drug: Tramadol suspension
Sponsors: Children's Hospitals and Clinics of Minnesota; Children's Hospitals and Clinics of Minnesota
Recruiting - verified September 2011 - Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: dextromethorphan hydrobromide; Drug: gamma-secretase/Notch signalling pathway inhibitor RO4929097; Drug: ketoconazole; Drug: midazolam hydrochloride; Drug: omeprazole; Drug: rifampin; Drug: tolbutamide
Sponsors: National Cancer Institute (NCI); University of Wisconsin, Madison; National Cancer Institute (NCI)
Recruiting - verified July 2011 - Condition: Substance Abuse Disorder
Interventions: Behavioral: Low intensity care; Behavioral: Voucher reinforcement
Sponsors: Johns Hopkins University; Johns Hopkins University; National Institute on Drug Abuse (NIDA)
Recruiting - verified August 2011 - Condition: Drug Dependence
Intervention: Drug: 2-4 of the drugs listed below
Sponsors: University of Arkansas; University of Arkansas; National Institute on Drug Abuse (NIDA)
Recruiting - verified February 2012 - Condition: Lower Urinary Tract Symptoms
Interventions: Drug: dutasteride 0.5 mg, used with tolterodine ER 4mg or placebo; Drug: dutasteride
Sponsors: Siami, Paul F., M.D.; Siami, Paul F., M.D.; GlaxoSmithKline; Pfizer
Recruiting - verified July 2011 - Conditions: Fracture; Pain, Postoperative
Interventions: Drug: Methadone; Drug: Morphine
Sponsors: University of Louisville; University of Louisville
Recruiting - verified August 2011 - Condition: Cocaine Dependence
Interventions: Drug: Galantamine; Drug: placebo
Sponsors: Yale University; Yale University; National Institute on Drug Abuse (NIDA)
Recruiting - verified April 2012 - Conditions: Bladder Cancer; Cervical Cancer; Esophageal Cancer; Gastric Cancer; Head and Neck Cancer; Kidney Cancer; Leukemia; Liver Cancer; Lung Cancer; Pancreatic Cancer; Tobacco Use Disorder
Interventions: Drug: nicotine; Drug: varenicline; Other: placebo
Sponsors: Butler Hospital; Butler Hospital; National Cancer Institute (NCI)
Recruiting - verified March 2012 - Conditions: Cocaine Dependence; Cocaine-Related Disorders; Opioid-Related Disorders
Interventions: Drug: Airipiprazole; Drug: Placebo
Sponsors: National Institutes of Health Clinical Center (CC); National Institute on Drug Abuse (NIDA)
Recruiting - verified July 2011 - Condition: Sickle Cell Disease
Interventions: Drug: Morphine; Drug: Methadone; Drug: Methadone
Sponsors: Washington University School of Medicine; Washington University School of Medicine
Recruiting - verified February 2012 - Condition: Cocaine Addictions
Interventions: Drug: sugar pill; Drug: carvedilol; Drug: Methadone
Sponsors: Yale University; Yale University; National Institute on Drug Abuse (NIDA)
Recruiting - verified December 2011
 |
Antitussive Agents Clinical Trials |
